July 29, 2014
Dr. Rula Abbud-Antaki receives 2 awards at the AACC 2014 Annual Meeting and Clinical Lab Expo for her poster presentation on the Falcon Breast Cancer Test, titled: "Identification of four molecular subclasses of Luminal Breast Cancer with Different likelihood of recurrence and response to Tamoxifen".
May 17, 2013
Falcon Genomics, Inc. receives notice of allowance for its Canadian Patent Application # 2,593,494.
Falcon Genomics, Inc. press release.
September 26, 2012
Publication of Cancer BioChip article in PLOS ONE.
Marhefka JN, Abbud-Antaki RA (2012) Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets.
May 29, 2012
Acceptance for publication in Hormones and Cancer of Cancer BioChip manuscript.
Abbud-Antaki RA, Marhefka JN, DeLuca AL, Zuromski MP (2012) The Cancer BioChip System: A functional genomic assay for anchorage-independent three-dimensional breast cancer cell growth. Hormones & Cancer, accepted.
December 1, 2011
Falcon Genomics, Inc. receives notice of allowance for its US Patent Application # 11/772,411.
October 6-7, 2011
Falcon Genomics, Inc. reports on the screening power of its Test Cancer BioChip in a poster titled: "Use of the Cancer Biochip System as a Tool for Identifying Therapeutic Targets in Personalizing Breast Cancer Treatment" at the Academic Screening Workshop, Bridgewater, NJ.
June 28, 2011
Dr. Rula Abbud-Antaki presents Falcon Genomics' Company Presentation at BIO 2011, Washington, DCFalcon Genomics, Inc. announces opening of its gene expression profiling service.